A 14-year-old boy named Ethan Griffiths is navigating a difficult relapse of Burkitt lymphoma, a fast-growing type of non-Hodgkin lymphoma. Diagnosed in January, Ethan initially beat the cancer by May, only to experience an aggressive relapse shortly after returning home. He is now participating in a clinical trial at Bristol Royal Hospital for children with B-cell non-Hodgkin lymphoma who have not responded to or have relapsed from treatment. This trial involves two new drugs and offers a 50% chance of success.
Ethan, who enjoys sports and gaming, described the return of his cancer as "much more heartbreaking" because he had begun reintegrating into daily life. He had attended school for half a day and was regularly going to the gym to regain fitness before receiving the news of his relapse, which he called "really horrendous."
His father, Lloyd, also a cancer survivor, advised Ethan to detach himself from the illness as a coping mechanism. While Ethan strived to remain positive, his father found the situation immensely stressful. The family has endured immeasurable stress throughout Ethan's journey.
Ethan was diagnosed with Burkitt lymphoma in January and completed chemotherapy, leading to remission in May. However, the cancer returned, prompting his family to seek out advanced treatment options. The clinical trial he is currently part of is a UK-wide initiative.
He found out his cancer had returned two weeks after successfully completing his initial treatment and returning home. The news came as a significant blow, disrupting his return to normalcy, including school and physical fitness activities.
